Filing Details
- Accession Number:
- 0000899243-19-026925
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-11-08 12:18:54
- Reporting Period:
- 2019-09-27
- Accepted Time:
- 2019-11-08 12:18:54
- Original Submission Date:
- 2019-10-01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1415684 | Musclepharm Corp | MSLP | () | 4/A |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1008190 | Mark Blundell | Co White Winston Select Asset Funds, Llc 265 Franklin St., Suite 1702 Boston MA 02110 | No | No | Yes | No | |
1559652 | P Robert Mahoney | Co White Winston Select Asset Funds, Llc 265 Franklin St., Suite 1702 Boston MA 02110 | No | No | Yes | No | |
1647702 | M. Todd Enright | Co White Winston Select Asset Funds, Llc 265 Franklin St., Suite 1702 Boston MA 02110 | No | No | Yes | No | |
1647837 | Donald Feagan | Co White Winston Select Asset Funds, Llc 265 Franklin St., Suite 1702 Boston MA 02110 | No | No | Yes | No | |
1647840 | White Winston Select Asset Funds, Llc | 265 Franklin St., Suite 1702 Boston MA 02110 | No | No | Yes | No | |
1738154 | White Winston Select Asset Fund Series Fund Mp-18, Llc | 265 Franklin St., Suite 1702 Boston MA 02115 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-09-27 | 93,852 | $0.00 | 3,021,529 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This Form 4 amends a Form 4 filed by the reporting person on October 1, 2019, which erroneously reported in (i) Table I, Column 4 that the number of securities acquired in the reported transaction was 103,677, rather than 93,852 and (ii) Table I, Column 5 that the amount of securities beneficially owned following the reported transaction was 3,031,354, rather than 3,021,529.